Clinical Trials Browser

Interventional × Breast Neoplasms × amrubicin × Clear all

NCT01033032 2022-05-03

Trial of Amrubicin as Treatment for Patients With HER2-Negative Metastatic Breast Cancer

Phase 1/2 Completed

78 enrolled 15 charts

Breast Neoplasms

NCT00380835 2008-09-23

Study of Amrubicin With or Without Herceptin in Patients With Metastatic Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms